eliglustat (Cerdelga)

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

  • start 42 mg PO BID
  • increase dose in 4 weeks
  • usual dose 84 mg PO BID

Capsule

Adverse effects

Mechanism of action

More general terms

References

  1. 1.0 1.1 FDA News Release. August 19. 2014. FDA approves new drug to treat a form of Gaucher disease. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm410585.htm

Database